The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women

Menopause. 2011 Jan;18(1):6-7. doi: 10.1097/gme.0b013e318203a46b.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Breast Neoplasms / epidemiology
  • Estrogen Antagonists / adverse effects
  • Estrogen Antagonists / therapeutic use*
  • Estrogens / agonists*
  • Female
  • Female Urogenital Diseases / chemically induced*
  • Female Urogenital Diseases / epidemiology
  • Humans
  • Indoles / adverse effects
  • Indoles / therapeutic use
  • Osteoporosis, Postmenopausal / drug therapy
  • Postmenopause / drug effects*
  • Pyrrolidines / adverse effects
  • Pyrrolidines / therapeutic use*
  • Raloxifene Hydrochloride / adverse effects
  • Raloxifene Hydrochloride / therapeutic use
  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators / adverse effects
  • Selective Estrogen Receptor Modulators / therapeutic use*
  • Tamoxifen / adverse effects
  • Tamoxifen / therapeutic use
  • Tetrahydronaphthalenes / adverse effects
  • Tetrahydronaphthalenes / therapeutic use*

Substances

  • Estrogen Antagonists
  • Estrogens
  • Indoles
  • Pyrrolidines
  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators
  • Tetrahydronaphthalenes
  • Tamoxifen
  • Lasofoxifene
  • Raloxifene Hydrochloride
  • bazedoxifene